Espec Corp. carries a market capitalization of 91.46B, placing it among publicly traded companies globally. Its enterprise value stands at 43.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 91.46B |
| Enterprise Value | 43.06B |
Espec Corp. currently has 21.83M shares outstanding.
| Shares Outstanding | 21.83M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Espec Corp. trades at a trailing price-to-earnings ratio of 16.88. The price-to-sales ratio is 1.61, and the price-to-book ratio stands at 1.24.
| PE Ratio | 16.88 |
| PS Ratio | 1.61 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Espec Corp. trades at an EV/EBITDA multiple of 10.12 and an EV/FCF ratio of 5,703.07. The EV/Sales ratio of 1.23 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.12 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.23 |
| EV / EBITDA | 10.12 |
| EV / EBIT | 10.12 |
| EV / FCF | 5,703.07 |
Espec Corp. maintains a current ratio of 3.27, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.16, indicating elevated leverage, while an interest coverage ratio of 425.40 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.27 |
| Quick Ratio | 0.97 |
| Debt / Equity | 2.16 |
| Debt / EBITDA | 0.27 |
| Interest Coverage | 425.40 |
Espec Corp. posts a return on equity of 7.66 and a return on invested capital of 5.90.
| Return on Equity (ROE) | 7.66 |
| Return on Assets (ROA) | 4.59 |
| Return on Invested Capital (ROIC) | 5.90 |
| Return on Capital Employed (ROCE) | 7.24 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.64 |
Over the trailing twelve months, Espec Corp. has paid 1.08B in income taxes, reflecting an effective tax rate of 24.50.
| Income Tax | 1.08B |
| Effective Tax Rate | 24.50 |
Espec Corp.'s stock has gained approximately 37.39968% over the past 52 weeks. The 50-day moving average sits at 3,873.60, while the 200-day moving average is 3,539.93.
| Beta (5Y) | N/A |
| 52-Week Price Change | 37.39968% |
| 50-Day Moving Average | 3,873.60 |
| 200-Day Moving Average | 3,539.93 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Espec Corp. generated 34.87B in revenue and converted that into 3.32B in net income, yielding earnings per share of 152.12. EBITDA reached 4.25B, while operating income came in at 4.25B.
| Revenue | 34.87B |
| Gross Profit | 12.51B |
| Operating Income | 4.25B |
| Pretax Income | 4.40B |
| Net Income | 3.32B |
| EBITDA | 4.25B |
| EBIT | 4.25B |
| Earnings Per Share (EPS) | 152.12 |
Espec Corp. holds 14.07B in cash and equivalents against 1.14B in total debt, resulting in a net debt position of -12.62B. Total book value stands at 45.33B, with working capital of 33.08B providing operational flexibility.
| Cash & Cash Equivalents | 14.07B |
| Total Debt | 1.14B |
| Net Debt | -12.62B |
| Equity (Book Value) | 45.33B |
| Book Value Per Share | 2,077.58 |
| Working Capital | 33.08B |
Espec Corp. operates with a gross margin of 35.87, reflecting its pricing power and cost economics. The operating margin of 12.20 and net profit margin of 9.51 provide insight into operational efficiency.
| Gross Margin | 35.87 |
| Operating Margin | 12.20 |
| Pretax Margin | 12.61 |
| Profit Margin | 9.51 |
| EBITDA Margin | 12.20 |
Espec Corp. posts an Altman Z-Score of 4.00, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.00 |